<html>
<head>PUBMED IDs for ZNF545</head>
<body bgcolor='#C5F0F2'><h1>ZNF545</h1><a href='https://pubmed.ncbi.nlm.nih.gov/22679109/'>A novel 19q13 nucleolar zinc finger protein suppresses tumor cell growth through inhibiting ribosome biogenesis and inducing apoptosis but is frequently silenced in multiple carcinomas.</a> April 5  2012<br><a href='https://pubmed.ncbi.nlm.nih.gov/25360542/'>Zinc-finger protein 545 inhibits cell proliferation as a tumor suppressor through inducing apoptosis and is disrupted by promoter methylation in breast cancer.</a> July 15  2014<br><a href='https://pubmed.ncbi.nlm.nih.gov/25714013/'>Poor survival is associated with the methylated degree of zinc-finger protein 545 (ZNF545) DNA promoter in gastric cancer.</a> December 15  2015<br><a href='https://pubmed.ncbi.nlm.nih.gov/26289056/'>Hypermethylation of ZNF545 is associated with poor prognosis in patients with early-stage hepatocellular carcinoma after thermal ablation.</a> January 6  2015<br><a href='https://pubmed.ncbi.nlm.nih.gov/27150632/'>Epigenetic identification of ZNF545 as a functional tumor suppressor in multiple myeloma via activation of p53 signaling pathway.</a> May 11  2016<br></body></html>
